Van Lanschot Kempen Investment Management’s Zimmer Biomet ZBH Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-796	Closed	-$78K	–	204
2020 Q1	$78K	Hold	796	–	–	0.01%	167
2019 Q4	$116K	Sell	796 -4,151	-84%	-$573K	0.01%	171
2019 Q3	$659K	Sell	4,947 -2,001	-29%	-$258K	0.05%	138
2019 Q2	$794K	Sell	6,948 -1,531	-18%	-$179K	0.07%	134
2019 Q1	$1.05M	Buy	+8,479	New	+$964K	0.1%	133

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Van Lanschot Kempen Investment Management's ZBH Position: Q2 2020 in Review

Van Lanschot Kempen Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 796 shares — an estimated $78K sold.

Van Lanschot Kempen Investment Management first reported a position in ZBH in Q1 2019 and held it in 5 quarters. The position peaked at $1.05M in Q1 2019. 946 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

Van Lanschot Kempen Investment Management reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
Van Lanschot Kempen Investment Management sold 796 Zimmer Biomet shares in Q2 2020, an estimated $78K.
Van Lanschot Kempen Investment Management first reported a position in Zimmer Biomet in Q1 2019 and held it in 5 quarters.
Van Lanschot Kempen Investment Management's Zimmer Biomet position peaked at $1.05M in Q1 2019.
946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.